Nov 5 (Reuters) - MoonLake Immunotherapeutics MLTX.O:
MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES PRICING OF $75 MILLION UNDERWRITTEN OFFERING
MOONLAKE IMMUNOTHERAPEUTICS - PRICES 7.1 MILLION CLASS A ORDINARY SHARES AT $10.50 EACH
Source text: ID:nGNX8w9Hv7
Further company coverage: MLTX.O
((Reuters.Briefs@thomsonreuters.com;))